ResearcherFudan University Shanghai Cancer CenterActive in the last 2 years

Yajia Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5831-5214; OpenAlex author ID A5090802873. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Tumor Volume Evaluation is a Superior Predictor of Prognosis Compared to RECIST in Metastatic Pancreatic Ductal Adenocarcinoma Undergoing Immunochemotherapy Last author DOI 10.21203/rs.3.rs-7634457/v1 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dingxia Liu · 1 shared paper, 2025 · strength 0.27
- Paper Tumor Volume Evaluation is a Superior Predictor of Prognosis Compared to RECIST in Metastatic Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-7634457/v1 ↗
Miaoyan Wei · 1 shared paper, 2025 · strength 0.27
- Paper Tumor Volume Evaluation is a Superior Predictor of Prognosis Compared to RECIST in Metastatic Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-7634457/v1 ↗
Xianjun Yu · 1 shared paper, 2025 · strength 0.27
- Paper Tumor Volume Evaluation is a Superior Predictor of Prognosis Compared to RECIST in Metastatic Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-7634457/v1 ↗
Si Shi · 1 shared paper, 2025 · strength 0.27
- Paper Tumor Volume Evaluation is a Superior Predictor of Prognosis Compared to RECIST in Metastatic Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-7634457/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.